This study investigates pancreatic cancer. The purpose of this study is to explore the potential effects of an investigational medication on this condition.
The study evaluates the safety and effectiveness of the investigational medication. It focuses on understanding how the medication impacts the condition.
- Who can participate: Adults aged 50 and older with pancreatic cancer and high blood pressure are eligible. Participants must have histologically confirmed metastatic or locally advanced pancreatic cancer.
- Study details: Participants will take the investigational medication. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.